ALEXANDRA LOY: Open Payments
NPI 1164913505 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$431 in 25 payments from 7 companies in 2025. Trend: 2023 $660 · 2024 $1,035 · 2025 $431
Food & beverage: $431
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $268 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| Novo Nordisk Inc | 3 | $46 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: QULIPTA, UBRELVY, REXULTI, VRAYLAR, Ozempic, AIRSUPRA, GVOKE HYPOPEN, MOUNJARO.
Industry payments across LA — which companies pay providers there.
